These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18797207)

  • 1. Subcutaneous panniculitislike T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol.
    Medhi K; Kumar R; Rishi A; Kumar L; Bakhshi S
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):558-61. PubMed ID: 18797207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytosis Showing Complete Resolution With the BFM90 Protocol: Case Report and Review of Literature.
    Singh S; Philip CC; John MJ
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):478-481. PubMed ID: 30730380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous T-cell lymphoma: report of two cases.
    Wasik F; Kołodziej T; Jeleń M; Pejcz J
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):62-6. PubMed ID: 9552760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous panniculitis-like T-cell lymphoma in a patient with long-term remission with standard chemotherapy.
    Zhang H; Gupta R; Wang JC; Lipton JF; Huang YW
    J Natl Med Assoc; 2007 Oct; 99(10):1190-2. PubMed ID: 17987923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
    Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
    Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous panniculitis-like T-cell lymphoma.
    Tomasini D; Berti E
    G Ital Dermatol Venereol; 2013 Aug; 148(4):395-411. PubMed ID: 23900161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome in a Child.
    Gupta V; Arava S; Bakhshi S; Vashisht KR; Reddy R; Gupta S
    Pediatr Dermatol; 2016; 33(2):e72-6. PubMed ID: 26764131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 19 cases of subcutaneous panniculitis T-cell lymphoma with literature review].
    Huang JJ; Cai MY; Ye S; Li ZM; Huang HQ; Lin TY
    Ai Zheng; 2009 Oct; 28(10):1093-9. PubMed ID: 19799820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature.
    Go RS; Wester SM
    Cancer; 2004 Sep; 101(6):1404-13. PubMed ID: 15368328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
    Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous panniculitis-like T-cell lymphoma in a child with trisomy 21.
    Mixon B; Drach L; Monforte H; Barbosa J
    Fetal Pediatr Pathol; 2010; 29(6):380-4. PubMed ID: 21043561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
    Kost Al M; Kost Alová M; Belada D; Laco J
    Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous panniculitic T-cell lymphoma and cytophagic histiocytic panniculitis.
    Yung A; Snow J; Jarrett P
    Australas J Dermatol; 2001 Aug; 42(3):183-7. PubMed ID: 11488712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary subcutaneous panniculitis-like T-cell cutaneous lymphoma: clinical presentation, treatment and prognosis].
    Lü Z; Shi YK; Zhou LQ; Qin Y; Dong M; Yang JL; Liu P; Zhang CG
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):350-3. PubMed ID: 20723432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.